Company Badge
USPTO Data Jan 1 1976 - Oct 27 2026
8 Patents
#5 in Pearl River, NY
#2,108 in New York
#35,954 in US
Rk Pharma Inc.
Forward Citations = 1
26 inventors:
Pearl River, NY, United States of America
Rk Pharma Inc.
Calculating rank
EPO Patents = 1
Forward Citations = 1
Loading Chart...
Loading Chart...
26 inventors (with patents filed for the assignee):
Ravishanker Kovi (5 out of 31 patents)
Jayaraman Kannappan (3 out of 8 patents)
Sushilkumar Dhanaji Patil (3 out of 4 patents)
4. Alex Kochukunju George (3 out of 4 patents)
5. Nirav Ishwarlal Khatri (3 out of 4 patents)
6. Sushrut Krishnaji Kulkarni (3 out of 5 patents)
7. Debjani Manoj Singh (2 out of 3 patents)
8. Kannan Essakimuthu Muthaiyyan (2 out of 3 patents)
9. Jay Shantilal Kothari (2 out of 2 patents)
10. Rajesh A Patel (1 out of 3 patents)
11. Jayaraman Rao Kannapan (1 out of 13 patents)
12. Hemant Mande (1 out of 3 patents)
13. Shivnath Sahebrao Patil (1 out of 4 patents)
14. Ritesh H Panchal (1 out of 1 patent)
15. Varun L Zambare (1 out of 1 patent)
8 patents:
Company Overview
RK Pharma Inc. is a leading pharmaceutical company that focuses on developing and manufacturing high-quality generic and branded prescription drugs. With state-of-the-art facilities and a team of experienced professionals, we aim to create affordable healthcare solutions for patients worldwide. Our commitment to quality and innovation sets us apart in the pharmaceutical industry.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Rk Pharma Inc.. Retrieved from https://idiyas.com/company/rk-pharma
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]